CEO Amir Heshmatpour Buys 9,000 Shares in NEONC Technologies Amid 30% Weekly Surge—Insider Confidence Signals Upside Potential

Insider Buying Surge at NEONC Technologies Holdings

The latest Form 4 filing on August 18, 2026 shows CEO and President Amir Heshmatpour purchasing 9,000 shares of NEONC at $5.54 each, bumping his direct stake to about 3.096 million shares. This acquisition follows a string of purchases over the past month—12,000 shares at $3.79 on August 14 and 3,000 shares at $4.37 on August 17—making the current transaction the sixth consecutive buy by the executive in a span of just ten days. The pattern suggests a sustained conviction in the company’s trajectory rather than a single opportunistic trade.

What It Means for Investors

NEONC’s stock is already in a robust uptrend, having risen 30 % over the week and 73 % on the month‑to‑date, with the 52‑week high just under $13. The CEO’s incremental stake is a positive signal: insiders are betting on the firm’s prospects. Investors should note, however, that the purchases are relatively modest in dollar terms (approximately $50,000 in total) and the share price has fluctuated around the $5–$6 range. This suggests confidence without a dramatic shift in valuation, but it does reinforce the narrative that the company’s leadership believes the market has undervalued NEONC’s healthcare technology platform.

A Profile of the Insider

Amir Heshmatpour has been a steady buyer since May 2025, with purchases ranging from a few thousand to over a million shares. His most aggressive buy was in November 2025, when he acquired 1.2 million shares at an undisclosed price, likely reflecting a strategic capital injection. Over the past year he has averaged around 15,000 shares per transaction, with an overall trend of increasing holdings rather than divesting. The fact that he holds additional family and entity shares (including HCWG LLC, KIG LLC, and AFH Holding & Advisory) indicates a layered ownership structure, yet his direct ownership remains the largest single block.

Implications for NEONC’s Future

The CEO’s buying spree dovetails with NEONC’s recent product development milestones and potential expansion into broader clinical markets. A sustained insider confidence can attract external investors, especially in a sector where technology and regulatory hurdles often dampen enthusiasm. Should the company continue to deliver on its R&D roadmap and secure new partnerships, the insider buying could be a harbinger of further upside. Conversely, if market sentiment shifts—evidenced by a decline in the current $5.64 price or a drop in social media buzz—insiders may hold off on future purchases.

Bottom Line

Amir Heshmatpour’s consistent buying activity, coupled with NEONC’s strong recent price performance, signals an insider belief in the company’s upside. For investors, this represents a potential endorsement of the firm’s strategy and technology, but it is wise to monitor broader market dynamics and the CEO’s future transactions to gauge whether this enthusiasm will translate into sustained growth.